The promise and challenge of using AI for lung cancer detection
Critical Point
English - June 05, 2020 16:00 - 37 minutes - 25.6 MB - ★★★★★ - 17 ratingsBusiness Technology milliman critical point insurance healthcare technology retirement property & casualty risk management insurtech financial services Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: What the CARES Act means for retirement plans
Next Episode: COVID-19 and the mortgage credit risk market
Artificial intelligence (AI) along with low-dose CT scans hold promise for the early detection of lung cancer, but there are challenges that come with scaling up this new technology. In this episode of Critical Point, Milliman’s Bruce Pyenson is joined by Jim Mulshine, a thoracic medical oncologist who spent 25 years at the National Cancer Institute and is now with Rush Medical Center. He outlines the promise AI holds in sifting through the reams of digital information from a CT scan to efficiently evaluate results and detect a myriad of diseases. But challenges in data quality and standardization must be addressed if the tool is to be used on a national or global level.
You can read the episode transcript on our website.